Create account to read this article for free
Get free access to a limited number of articles.
The venture capital cycle is complete – we are back where we started
A new report from the research firm PitchBook has mapped the venture capital footprint in the biotechnology sector between 2012 and 2024. The report states that we have been through a complete cycle of "boom, bust and...
Previous chronicles
Early signs of spring in an otherwise frosty biotech landscape
Trump is once again waving tariff threats – are they just empty words?
Bispecific and Chinese the new black in cancer
The venture capital cycle is complete – we are back where we started
There are too many turns – the market needs to rest
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account